This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRINOX vs. Gemcitabine/Nab-Paclitaxel in De Novo Metastatic PDAC"

By ecancer FEATURING Jennifer Knox
By ecancer FEATURING Jennifer Knox
196 views
June 20, 2024
Comments 0
Login to view comments. Click here to Login